NIKE, Inc. (NYSE:NKE) – Large Cap Morning Report By

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
NIKE, Inc. (NYSE:NKE) – Large Cap Morning Report
By Brady Hawke -
December 16, 2015
53

Wall Street Observer – Large Cap Morning Report

Company Snapshot



NIKE, Inc. (NYSENKE), from the Consumer Goods sector had a price of $ *TBA today, indicating a change of *TBA.

The company is predicting an earnings per share growth of 14.33% in the coming year. The earnings per share growth over the next five years will be . NIKE, Inc. had an earnings per share growth of 13.90% in the last 5 years.

Currently the return on equity is 28.10% and its debt to equity is *TBA. NIKE, Inc. has a total market cap of $ 109600.16, a gross margin of *TBA while the profit margin is *TBA and the ROI is 23.20%



Performance

The stats on NIKE, Inc. are currently as follows.

The weekly performance is *TBA, and the quarterly performance is at *TBA. The monthly performance is *TBA and the yearly performance is *TBA. The performance for Year to Date (YTD) is *TBA.

NIKE, Inc. has earnings per share of $ 3.96 and the earnings per share growth for this year is 24.60%. The ROI is 23.20% and the return on equity for NIKE, Inc.as stated earlier, is currently at 28.10%.The return on assets (ROA) for NIKE, Inc. is 17.00%.

The earnings per share (EPS) is a direct measure of a company’s profit. EPS is calculated by subtracting dividends from profits and dividing it by the total number of shares outstanding.

The return on investment (ROI) is the money a company has made or lost on an investment – in simple terms.

The return on equity (ROE) measures the company’s profitability and the efficiency at which it is generating those profits. ROE is calculated by dividing the total profit by total amount of money invested in the company.

The return on assets (ROA) is a very useful indicator that illustrates how profitable a company really is in relation to its total assets. ROA is calculated by dividing the total annual earnings by the company’s total assets.



Dividends and Price Earnings Ratio

NIKE, Inc. has a dividend yield of 1.00%. The price/earnings ratio (P/E) is 32.48 and the forward P/E ratio stands at 26.12. The price to earnings growth is 2.57 and the price to sales growth is 3.53.

The price/earnings ratio (P/E) is one of the best known investment valuation indicators. P/E is calculated by dividing the trailing 12 months’ earnings per share by the present share price. Typically, a high P/E ratio means that the investors are paying more for today’s earnings in hopes of future growth in earnings.

The forward price to earnings ratio, as the name suggests, is used to find the future price to earnings ratio. It is calculated by dividing the market price per share with the anticipated earnings per share.

The price to earnings growth ratio (PEG) is utilized for determining a stock’s value in relation to the company’s earnings. It helps to provide a more holistic picture with the P/E ratio. The PEG is calculated by dividing the price to earnings ratio by the annual earnings per share growth. The lower the PEG ratio, the more the stock is undervalued in relation to its earnings performance.

Volume

NIKE, Inc. has a 52-week low of *TBA and 52-week high of *TBA. The company has a 20-day simple moving average of *TBA and a volume of *TBA. The average volume stands around *TBA.

Volume is the amount of shares that trade hands – in simple terms.

Technical

The technical stats for NIKE, Inc. are as follows.

NIKE, Inc. has a simple moving average of *TBA over the last 20 days. The simple moving average for the last 200 days stands at *TBA. NIKE, Inc. has a beta of *TBA and the weekly and monthly volatility stands at *TBA and *TBA respectively.

A simple moving average (SMA) is calculated by adding the closing price of the stock for the given time periods, say for 20 days, and then dividing it by that time period- i.e 20. It usually helps to smooth out the ‘noise’ by filtering out random price movements. Since SMA is based on past data, it will tend to have a lag. The longer the time period the greater the lag. So a 20-day SMA will have less lag than the 200-day SMA. Shorter SMAs are used for short-term trading and vice versa.

Beta is used to measure the volatility of the stock. A beta of less than 1 means that it is less volatile than the market and a beta of greater than 1 means that it is more volatile than the market. A beta of 1 indicates that the stock will move with the market.

Volatility, in simple terms, is an indicator of how risky the stock is. It is the amount of uncertainty or riskabout the magnitude of changes in a stock’s value. Higher volatility means that a stock’s price can change radically in either direction in a very short period of time and lower volatility is just the opposite, as the price doesn’t change dramatically – instead it varies at a steady pace over a significantly longer period of time.



Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.

Read more at http://www.wsobserver.com/nike-inc-nysenke-la...0c2iZpF.99
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 175

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 428

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 0

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 105

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading

Top 5 Most Recently Viewed Articles

Sands China Earns S&P Global ESG Top 1% Honors Again

Updated Category News Views 6

Breaking Down Sands China's Sustainability Triumph In the business realm, nabbing top spots in ESG is no walk in the park. Yet here’s Sands China, storming into 2026 with its fourth consecutive Top 1% spot in S&P Global’s Sustainability Yearbook for China and a hat-trick running for the global edition. That’s a fancy accolade in a space where sustainability ain't...

Continue Reading
Trailblazer Merger Corp I Raises Borrowing Limit for Growth

Updated Category News Views 56

Trailblazer Merger Corp I Enhances Financial Strength Trailblazer Merger Corporation I (NASDAQ:TBMC), a well-known special purpose acquisition company, has taken substantial steps to boost its financial capabilities. The company recently modified its borrowing agreement, which includes an increase in its credit line and an extension of the loan’s maturity date, as...

Continue Reading
Year-Round Joy: Transforming Lives with Toys for Tots

Updated Category News Views 128

Spreading Joy All Year Long with Marine Toys for Tots Why limit the spirit of giving to just one season? Marine Toys for Tots actively cultivates a culture of joy and generosity, ensuring that the joy of the holiday season extends far beyond December. As America's leading charity for children during the holidays, their mission resonates deeply throughout the year,...

Continue Reading
Unearthing History: The Remarkable Bronze Age Town in Arabia

Updated Category News Views 124

Unearthing the Significant Bronze Age Town The landscape of northwest Arabia has just revealed a stunning archaeological gem: an ancient Bronze Age town that challenges conventional notions about the region's historical trajectory. This remarkable discovery, made in the Khaybar oasis, brings insights into the transition from nomadic lifestyles to structured town living, a...

Continue Reading
Discover Perlick's Innovative Beverage Centers and Wine Columns

Updated Category News Views 199

Perlick’s New Column Beverage Centers and Wine Columns Perlick is introducing a fresh take on how you store and show off what you drink: all-new column beverage centers and wine columns built to raise the everyday experience. The company’s roots go back to 1917, and that century-plus of know?how shows up here—thoughtful engineering, clean design, and durable...

Continue Reading